Abstract
RB, a well known tumour suppressor that functions in the control of cell cycle progression and proliferation, has recently been shown to have additional functions in the maintenance of genomic stability, such that inactivation of RB family proteins promotes chromosome instability (CIN) and aneuploidy. Several studies have provided potential explanations for these phenomena that occur following RB loss, and they suggest that this new function of RB may contribute to its role in tumour suppression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baker, D. J., Jin, F., Jeganathan, K. B. & van Deursen, J. M. Whole chromosome instability caused by Bub1 insufficiency drives tumorigenesis through tumor suppressor gene loss of heterozygosity. Cancer Cell 16, 475–486 (2009).
Sotillo, R. et al. Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9–23 (2007).
Weaver, B. A., Silk, A. D., Montagna, C., Verdier-Pinard, P. & Cleveland, D. W. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11, 25–36 (2007).
Amato, A., Schillaci, T., Lentini, L. & Di Leonardo, A. CENPA overexpression promotes genome instability in pRb-depleted human cells. Mol. Cancer 8, 119 (2009).
Coschi, C. H. et al. Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev. 24, 1351–1363 (2010).
Dimaras, H. et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum. Mol. Genet. 17, 1363–1372 (2008).
Iovino, F., Lentini, L., Amato, A. & Di Leonardo, A. RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol. Cancer 5, 38 (2006).
Manning, A. L., Longworth, M. S. & Dyson, N. J. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 24, 1364–1376 (2010).
Schvartzman, J. M., Duijf, P. H., Sotillo, R., Coker, C. & Benezra, R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701–714 (2011).
Choi, C. M. et al. Chromosomal instability is a risk factor for poor prognosis of adenocarcinoma of the lung: fluorescence in situ hybridization analysis of paraffin-embedded tissue from Korean patients. Lung Cancer 64, 66–70 (2009).
Gao, C. et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc. Natl Acad. Sci. USA 104, 8995–9000 (2007).
Heilig, C. E. et al. Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group. J. Cell. Mol. Med. 14, 895–902 (2010).
Kuukasjarvi, T. et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res. 57, 1597–1604 (1997).
McClelland, S. E., Burrell, R. A. & Swanton, C. Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy. Cell Cycle 8, 3262–3266 (2009).
Nowell, P. C. The clonal evolution of tumor cell populations. Science 194, 23–28 (1976).
Rajagopalan, H. & Lengauer, C. Aneuploidy and cancer. Nature 432, 338–341 (2004).
Swanton, C. et al. Chromosomal instability determines taxane response. Proc. Natl Acad. Sci. USA 106, 8671–8676 (2009).
Sotillo, R., Schvartzman, J. M., Socci, N. D. & Benezra, R. Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature 464, 436–440 (2010).
Manning, A. L. & Dyson, N. J. pRB, a tumor suppressor with a stabilizing presence. Trends Cell Biol. 21, 433–441 (2011).
Chakraborty, S. et al. Identification of genes associated with tumorigenesis of retinoblastoma by microarray analysis. Genomics 90, 344–353 (2007).
Ishida, S. et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21, 4684–4699 (2001).
Knudsen, E. S. & Knudsen, K. E. Tailoring to RB: tumour suppressor status and therapeutic response. Nature Rev. Cancer 8, 714–724 (2008).
Hernando, E. et al. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430, 797–802 (2004).
Michel, L. S. et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409, 355–359 (2001).
Amato, A., Lentini, L., Schillaci, T., Iovino, F. & Di Leonardo, A. RNAi mediated acute depletion of retinoblastoma protein (pRb) promotes aneuploidy in human primary cells via micronuclei formation. BMC Cell Biol. 10, 79 (2009).
Diaz-Rodriguez, E., Sotillo, R., Schvartzman, J. M. & Benezra, R. Hec1 overexpression hyperactivates the mitotic checkpoint and induces tumor formation in vivo. Proc. Natl Acad. Sci. USA 105, 16719–16724 (2008).
Zheng, L., Chen, Y., Riley, D. J., Chen, P. L. & Lee, W. H. Retinoblastoma protein enhances the fidelity of chromosome segregation mediated by hsHec1p. Mol. Cell. Biol. 20, 3529–3537 (2000).
Carter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N. & Szallasi, Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nature Genet. 38, 1043–1048 (2006).
Mayhew, C. N. et al. RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis. Gastroenterology 133, 976–984 (2007).
Niculescu, A. B. et al. Effects of p21Cip1/Waf1 at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18, 629–643 (1998).
Srinivasan, S. V., Mayhew, C. N., Schwemberger, S., Zagorski, W. & Knudsen, E. S. RB loss promotes aberrant ploidy by deregulating levels and activity of DNA replication factors. J. Biol. Chem. 282, 23867–23877 (2007).
Storchova, Z. & Kuffer, C. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121, 3859–3866 (2008).
Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435–446 (2011).
Morris, E. J. & Dyson, N. J. Retinoblastoma protein partners. Adv. Cancer Res. 82, 1–54 (2001).
Ren, B. et al. E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev. 16, 245–56 (2002).
Barbie, D. A. et al. Nuclear reorganization of mammalian DNA synthesis prior to cell cycle exit. Mol. Cell. Biol. 24, 595–607 (2004).
Knudsen, K. E. et al. RB-dependent S-phase response to DNA damage. Mol. Cell. Biol. 20, 7751–7763 (2000).
Bosco, E. E. et al. RB signaling prevents replication-dependent DNA double-strand breaks following genotoxic insult. Nucleic Acids Res. 32, 25–34 (2004).
van Harn, T. et al. Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev. 24, 1377–1388 (2010).
Harrington, E. A., Bruce, J. L., Harlow, E. & Dyson, N. pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc. Natl Acad. Sci. USA 95, 11945–11950 (1998).
Cobrinik, D. Pocket proteins and cell cycle control. Oncogene 24, 2796–2809 (2005).
Bourgo, R. J. et al. RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control. Mol. Cell 43, 663–672 (2011).
Mikhailov, A., Cole, R. W. & Rieder, C. L. DNA damage during mitosis in human cells delays the metaphase/anaphase transition via the spindle-assembly checkpoint. Curr. Biol. 12, 1797–1806 (2002).
Frame, F. M., Rogoff, H. A., Pickering, M. T., Cress, W. D. & Kowalik, T. F. E2F1 induces MRN foci formation and a cell cycle checkpoint response in human fibroblasts. Oncogene 25, 3258–66 (2006).
Pickering, M. T. & Kowalik, T. F. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation. Oncogene 25, 746–755 (2006).
Eguchi, T., Takaki, T., Itadani, H. & Kotani, H. RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene 26, 509–520 (2007).
Jackson, M. W. et al. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2. J. Cell Sci. 118, 1821–1832 (2005).
Garcia-Cao, M., Gonzalo, S., Dean, D. & Blasco, M. A. A role for the Rb family of proteins in controlling telomere length. Nature Genet. 32, 415–419 (2002).
Gonzalo, S. et al. Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin. Nature Cell Biol. 7, 420–428 (2005).
Isaac, C. E. et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26, 3659–3671 (2006).
Longworth, M. S., Herr, A., Ji, J. Y. & Dyson, N. J. RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev. 22, 1011–1024 (2008).
Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601 (1998).
Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).
Lai, A. et al. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol. Cell. Biol. 19, 6632–6641 (1999).
McCabe, M. T., Davis, J. N. & Day, M. L. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res. 65, 3624–3632 (2005).
Nasmyth, K. & Haering, C. H. Cohesin: its roles and mechanisms. Annu. Rev. Genet. 43, 525–558 (2009).
Ng, T. M., Waples, W. G., Lavoie, B. D. & Biggins, S. Pericentromeric sister chromatid cohesion promotes kinetochore biorientation. Mol. Biol. Cell 20, 3818–3827 (2009).
Skibbens, R. V. Establishment of sister chromatid cohesion. Curr. Biol. 19, R1126–R1132 (2009).
Cimini, D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim. Biophys. Acta 1786, 32–40 (2008).
Terret, M. E., Sherwood, R., Rahman, S., Qin, J. & Jallepalli, P. V. Cohesin acetylation speeds the replication fork. Nature 462, 231–234 (2009).
Mannini, L., Menga, S. & Musio, A. The expanding universe of cohesin functions: a new genome stability caretaker involved in human disease and cancer. Hum. Mutat. 31, 623–630 (2010).
Lightfoot, J., Testori, S., Barroso, C. & Martinez-Perez, E. Loading of meiotic cohesin by SCC-2 is required for early processing of DSBs and for the DNA damage checkpoint. Curr. Biol. 21, 1421–1430 (2011).
Cimini, D. et al. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J. Cell Biol. 153, 517–527 (2001).
Ganem, N. J., Godinho, S. A. & Pellman, D. A mechanism linking extra centrosomes to chromosomal instability. Nature 460, 278–282 (2009).
Thompson, S. L. & Compton, D. A. Examining the link between chromosomal instability and aneuploidy in human cells. J. Cell Biol. 180, 665–672 (2008).
Daum, J. R. et al. Cohesion fatigue induces chromatid separation in cells delayed at metaphase. Curr. Biol. 21, 1018–1024 (2011).
Janssen, A., van der Burg, M., Szuhai, K., Kops, G. J. & Medema, R. H. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 333, 1895–1898 (2011).
Zhang, J. et al. A novel retinoblastoma therapy from genomic and epigenitic analyses. Nature 11 Jan 2012 (doi: 10.1038/nature10733).
Roschke, A. V. et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res. 63, 8634–8647 (2003).
Acknowledgements
We thank D. Compton and L. Kabeche for sharing their unpublished data, N. Ganem for critical reading and suggestions on the manuscript, and the reviewers for their helpful comments. This work was supported by an American Cancer Society Fellowship to A.L.M., the Massachusetts General Hospital Cancer Center Saltonstall Foundation Scholarship to N.J.D., and funding from AstraZeneca and NIH grants GM81607 and CA64402 to N.J.D.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Manning, A., Dyson, N. RB: mitotic implications of a tumour suppressor. Nat Rev Cancer 12, 220–226 (2012). https://doi.org/10.1038/nrc3216
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3216
This article is cited by
-
E2F1 promotes cell cycle progression by stabilizing spindle fiber in colorectal cancer cells
Cellular & Molecular Biology Letters (2022)
-
Synthetic lethality in personalized cancer therapy
Genome Instability & Disease (2022)
-
Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Oncogene (2022)
-
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion
Oncogene (2020)
-
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?
Current Oncology Reports (2020)